These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 6147145)
1. Beta-adrenoceptor antagonists and human platelets: relationship of effects to lipid solubility. Kerry R; Scrutton MC; Wallis RB Biochem Pharmacol; 1984 Aug; 33(16):2615-22. PubMed ID: 6147145 [TBL] [Abstract][Full Text] [Related]
2. Influence of some beta blockers (pindolol, atenolol, timolol and metoprolol) on aggregation and arachidonic acid metabolism in human platelets. Srivastava KC Prostaglandins Leukot Med; 1987 Sep; 29(1):79-84. PubMed ID: 2890173 [TBL] [Abstract][Full Text] [Related]
3. Effect of phorbol 12-myristate 13-acetate (PMA) on agonist-induced arachidonate release and 5-hydroxytryptamine secretion in human platelets. Dependence of effects on agonist type and time of incubation with PMA. Krishnamurthi S; Joseph S; Kakkar VV Biochim Biophys Acta; 1987 Mar; 927(3):429-36. PubMed ID: 3101746 [TBL] [Abstract][Full Text] [Related]
4. Comparison of the effects of carvedilol, propranolol, and verapamil on in vitro platelet function in healthy volunteers. Gasser JA; Betterridge DJ J Cardiovasc Pharmacol; 1991; 18 Suppl 4():S29-34. PubMed ID: 1721976 [TBL] [Abstract][Full Text] [Related]
5. Regulation of human platelet activation--analysis of cyclooxygenase and cyclic AMP-dependent pathways. Krishnamurthi S; Westwick J; Kakkar VV Biochem Pharmacol; 1984 Oct; 33(19):3025-35. PubMed ID: 6091666 [TBL] [Abstract][Full Text] [Related]
6. Influence of phentolamine on platelet aggregation, thromboxane B2 production and release reaction. Anfossi G; Trovati M; Mularoni E; Lanzio M; Massucco P; Emanuelli G Arch Int Pharmacodyn Ther; 1988; 296():144-54. PubMed ID: 2853612 [TBL] [Abstract][Full Text] [Related]
7. Influence of propranolol, pindolol, practolol and talinolol on arachidonic acid (AA)- and U-46619-induced aggregation and on AA-induced thromboxane A2 formation in platelets. Heinroth I; Block HU; Pönicke K; Förster W Prostaglandins Leukot Med; 1983 Oct; 12(2):189-206. PubMed ID: 6139824 [TBL] [Abstract][Full Text] [Related]
8. A comparative study of the effects of adrenoceptor antagonists on platelet aggregation and thromboxane generation. Greer IA; Walker JJ; McLaren M; Calder AA; Forbes CD Thromb Haemost; 1985 Aug; 54(2):480-4. PubMed ID: 2867620 [TBL] [Abstract][Full Text] [Related]
9. Factors influencing the response of human blood platelets to analogues of ADP which may act as partial agonists at the ADP receptor. Egan CM; Fisher AP; Scrutton MC Eur J Biochem; 1979 Mar; 95(1):127-37. PubMed ID: 110586 [TBL] [Abstract][Full Text] [Related]
10. Effects of trifluoperazine on platelet activation. Ardlie NG; Boatwright C; Garrett J; McGuiness JA Thromb Res; 1985 Jun; 38(6):695-706. PubMed ID: 3161211 [TBL] [Abstract][Full Text] [Related]
11. Phenothiazine compounds enhance phentolamine effects on platelet aggregation and thromboxane B2 production. Anfossi G; Trovati M; Mularoni E; Massucco P; Cavalot F; Mattiello L; Emanuelli G Arch Int Pharmacodyn Ther; 1990; 307():142-61. PubMed ID: 1982777 [TBL] [Abstract][Full Text] [Related]
12. [The role of prostaglandins in the effect of beta-blockers on stimulated blood platelets]. Nosál' R; Jancinová V; Petríková M Vnitr Lek; 1991 Mar; 37(3):261-7. PubMed ID: 1674390 [TBL] [Abstract][Full Text] [Related]
13. Theophylline inhibits platelet aggregation, prostaglandin and thromboxane production by a mechanism which is independent of cyclic AMP. Burns GB; Dodge JA Agents Actions; 1984 Jan; 14(1):102-8. PubMed ID: 6322546 [TBL] [Abstract][Full Text] [Related]
14. Adrenaline infusion evokes increased thromboxane B2 production by platelets in healthy men: the effect of beta-adrenoceptor blockade. Laustiola K; Kaukinen S; Seppälä E; Jokela T; Vapaatalo H Eur J Clin Invest; 1986 Dec; 16(6):473-9. PubMed ID: 2881786 [TBL] [Abstract][Full Text] [Related]
15. Arachidonate metabolism, 5-hydroxytryptamine release and aggregation in human platelets activated by palmitaldehyde acetal phosphatidic acid. Brammer JP; Maguire MH Br J Pharmacol; 1984 May; 82(1):61-72. PubMed ID: 6428500 [TBL] [Abstract][Full Text] [Related]
16. Effects of three beta-blockers with different pharmacodynamic properties on platelet aggregation and platelet and plasma cyclic AMP. Winther K; Trap-Jensen J Eur J Clin Pharmacol; 1988; 35(1):17-20. PubMed ID: 2905989 [TBL] [Abstract][Full Text] [Related]
17. Alterations in lipid peroxidation of thrombin-stimulated rat platelets treated with beta-adrenoceptor blocking drugs. Nosál R; Petríková M; Jancinová V J Lipid Mediat; 1993 Oct; 8(2):121-32. PubMed ID: 7903565 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of collagen-induced platelet aggregation and adhesion by a pseudocyanide derivative of avicine isolated from Zanthoxylum integrifoliolum Merr. Ko FN; Hsiao G; Chen IS; Wu SJ; Teng CM Biochem Pharmacol; 1993 Oct; 46(7):1165-73. PubMed ID: 8216367 [TBL] [Abstract][Full Text] [Related]
19. Cyclic adenosine 3',5'-monophosphate inhibits the availability of arachidonate to prostaglandin synthetase in human platelet suspensions. Minkes M; Stanford N; Chi MM; Roth GJ; Raz A; Needleman P; Majerus PW J Clin Invest; 1977 Mar; 59(3):449-54. PubMed ID: 190267 [TBL] [Abstract][Full Text] [Related]
20. Regulatory role of cyclic adenosine 3',5'-monophosphate on the platelet cyclooxygenase and platelet function. Fitzpatrick FA; Gorman RR Biochim Biophys Acta; 1979 Jan; 582(1):44-58. PubMed ID: 216415 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]